Heart diseases are one of the leading causes of death worldwide. For this reason, numerous medical advancements have been made to help people with heart conditions lead a normal life. One of the innovations that have revolutionized the treatment of heart conditions is the Watchman Heart Device – a device used in patients with Atrial Fibrillation (AFib). In this article, we will delve deep into the functionality of Watchman Heart Devices.

What is a Watchman device?

The Watchman Heart Device is a one-time implantable device designed to help patients with AFib. With AFib, the irregular beating of the upper chambers of the heart may lead to clots forming in the left atrial appendage (LAA). In patients with this condition, the LAA is occluded using a Watchman Heart Device. The device is a small, umbrella-like structure that blocks the LAA, preventing clots from being formed.

How does it work?

As mentioned earlier, the Watchman device blocks the LAA to prevent blood clots from being formed. It is through clot formation that AFib patients are at risk of stroke. Once the device is implanted, it does not require any maintenance or adjustments. The device is meant to be a permanent solution to reduce the risk of stroke in AFib patients. After implantation, patients must still take blood-thinning medications for 45 days after the procedure while the device completely heals.

Why choose a Watchman device?

Watchman devices hold several benefits over medications, which are traditionally used to prevent blood clots in AFib patients. Firstly, they are a permanent solution to the risk of forming blood clots. Secondly, patients are less likely to experience bleeding complications, which may occur as a result of taking blood thinners. Thirdly, once a patient has a Watchman device implanted, they are no longer required to go through the hassle of daily monitoring, which can be time-consuming and expensive.

Who is a candidate for a Watchman device?

The Watchman device is an excellent solution for patients who cannot tolerate blood-thinning medications or are at increased risk of bleeding. Candidates for a Watchman device include patients with a history of bleeding or stroke, patients over 65 years old, or patients with a history of falls or injuries.

Conclusion:

AFib is a condition that can have severe consequences, but with modern medicine, risks can be reduced. Watchman Heart Devices are a significant breakthrough in the treatment of AFib, protecting patients from stroke in a more permanent and straightforward way than blood-thinning medications. It is essential, however, to work with a healthcare provider to assess if a Watchman Heart Device is the right treatment option for you. The procedure requires specific criteria to be met, and it is essential to weigh those risks with the potential benefits.